Intrinsiqq
Lytix Biopharma ASA logo

Lytix Biopharma ASA

LYTIX.XOSL

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market CapNOK 703M
EPS-NOK 1.30
P/E-0.67
P/FCF-8.08
EV/EBITDA-6.39
FCF Yield–
Div. Yield–
Net Debt/FCF0.8x
Lytix Biopharma ASA intrinsic value
52-Week Range
€0.66€1.02

Profitability & Returns

Revenue (TTM)

NOK 0.00

▼ -100.0% YoY

Net Income (TTM)

-NOK 95M

▲ +36.4% YoY

Op. Margin

–

ROIC

-57.98%

▲ +35.4pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-NOK 87M

▲ +15.0% YoY

Op. Cash Flow (TTM)

-NOK 87M

▲ +15.0% YoY

Net Debt

-NOK 69M

Net Cash Position

Cash & Equiv.

NOK 72M

Continue Research

Peers

Biotechnology · Pick stocks to compare with LYTIX.XOSL

CompareIntrinsic value
SOFTX.XOSLSoftOx Solutions AS
€0.01+0.00%10
HBC.XOSLHofseth BioCare ASA
€0.09+0.00%30
NAVA.XOSLNavamedic ASA
€0.98+1.03%29
ONCIN.XOSLOncoinvent ASA
kr 67.40-2.60%50
ZLNA.XOSLZelluna ASA
€1.46+1.04%20
VISTN.XOSLVistin Pharma ASA
€1.80+0.56%81
PHO.XOSLPhotocure ASA
kr 42.05-2.44%88
OMDA.XOSLOmda A/S
€4.34+2.60%42

Lytix Biopharma ASA (LYTIX.XOSL) in three numbers

Quality score
10/100
Best check: net debt, -$69M. Weakest: return on capital, -58.0%.
Quality
Dividend
None
No dividend in the company filings we hold.
Dividends
P/E
-0.67
Negative: a loss over the last twelve months. Price to free cash flow -8.08.
Financials

Questions about Lytix Biopharma ASA

Is Lytix Biopharma ASA a high-quality business?

Lytix Biopharma ASA scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from company filings. Its best check is net debt at -$69M, and its weakest is return on capital at -58.0%. The Quality tab shows every check against its target.

Does Lytix Biopharma ASA (LYTIX.XOSL) pay a dividend?

No. Lytix Biopharma ASA (LYTIX.XOSL) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: company filings. Price: last close 16 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing LYTIX.XOSL

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.